Branched‐Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice
Daria M. Strelkova Petersen(Carnegie Mellon University), Kathryn A. Whitehead(Carnegie Mellon University), Khalid A. Hajj(Carnegie Mellon University), Ryan M. Weiss(Carnegie Mellon University), Namit Chaudhary(Scripps Research Institute), Saigopalakrishna S. Yerneni(Carnegie Mellon University), Alexandra N. Newby(Carnegie Mellon University), Mariah L. Arral(Carnegie Mellon University)
Cited by 40
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628
Managing diabetes with nanomedicine: challenges and opportunities
|Nature Reviews Drug Discovery|2014|608
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
|Journal of Controlled Release|2022|270